Article
Determining novel candidate anti-hepatocellular carcinoma drugs using interaction networks and molecular docking between drug targets and natural compounds of SiNiSan
16 Feb 2021
Abstract excerpt
BACKGROUND: SiNiSan (SNS) is an ancient traditional Chinese medicine (TCM) used to treat liver and spleen deficiencies. We studied the unique advantages of using SNS to treat hepatocellular carcinoma (HCC) with multiple components and targets to determine its potential mechanism of action. METHODS: The active compounds from the individual herbs in the SNS formula and their targets were mined from Traditional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
